1. Home
  2. FDBC vs FULC Comparison

FDBC vs FULC Comparison

Compare FDBC & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fidelity D & D Bancorp Inc.

FDBC

Fidelity D & D Bancorp Inc.

SELL

Current Price

$58.69

Market Cap

319.9M

Sector

Finance

ML Signal

SELL

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

SELL

Current Price

$3.66

Market Cap

285.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FDBC
FULC
Founded
1902
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.9M
285.4M
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
FDBC
FULC
Price
$58.69
$3.66
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
★ $3.67
AVG Volume (30 Days)
7.7K
★ 1.4M
Earning Date
10-30-2026
10-28-2026
Dividend Yield
★ 2.97%
N/A
EPS Growth
★ 35.00
N/A
EPS
★ 2.63
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.99
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$41.00
$2.83
52 Week High
$58.77
$15.74

Technical Indicators

Market Signals
Indicator
FDBC
FULC
Relative Strength Index (RSI) 63.02 38.55
Support Level $53.13 $3.62
Resistance Level N/A $3.91
Average True Range (ATR) 1.09 0.06
MACD 0.24 -0.00
Stochastic Oscillator 81.06 3.70

Price Performance

Historical Comparison
FDBC
FULC

About FDBC Fidelity D & D Bancorp Inc.

Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), the company provides a full range of banking, trust and financial services to individuals, small businesses and corporate customers. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. The company's segments include: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate, with the majority of revenue generating from the Commercial Real Estate segment.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Share on Social Networks: